The gastrointestinal side effects commonly associated with semaglutideparticularly nausea, vomiting, and diarrheacan lead to reduced fluid intake and increased fluid losses
Also, keep the pen away from the cooling part of the fridge (usually at the back or top of the fridge), because it might get too cold or even freeze
a fall from over 8 rungs is potentially fatal
By binding to GLP-1 receptors in the pancreas, brain, and gut, semaglutide: Stimulates insulin release only when blood glucose is elevated, which significantly reduces hypoglycaemia risk compared to older diabetes drugs Suppresses glucagon reducing the livers release of stored glucose into the bloodstream Slows gastric emptying food leaves the stomach more slowly, producing prolonged fullness and reducing overall caloric intake Acts on the brains appetite centres reducing hunger signals and food cravings Mounjaro (Tirzepatide): Dual GLP-1 + GIP Receptor Agonist Tirzepatide activates the same GLP-1 receptor as semaglutide but also activates a second receptor: the glucose-dependent insulinotropic polypeptide (GIP) receptor
This can lead to severe abdominal pain, bloating, inability to pass gas or stool, and vomiting
Aprende ms sobre el A1C y datos sobre el peso
